US 11419869
Dosage forms and regimens for amino acid compounds
granted A61KA61K31/4375A61K31/4439
Quick answer
US patent 11419869 (Dosage forms and regimens for amino acid compounds) held by Pliant Therapeutics, Inc. expires Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Pliant Therapeutics, Inc.
- Grant date
- Tue Aug 23 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 72
- CPC classes
- A61K, A61K31/4375, A61K31/4439, A61K31/496, A61K31/498